Dr. Apter represents GCT at MiXii Biomed 2017

GCT President, Dr. Jeffrey Apter had an intense set of meetings during MiXii Biomed 2017 in Tel-Aviv, Israel. We look forward to fruitful long-lasting collaboration with new partners from biotech, medical device and pharmaceutical industries!

Updated: May 26, 2017

Permanent link: https://2022.gctrials.com/posts/dr-apter-visiting-mixii-biomed-2017/

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2021 Global Clinical Trials, LLC

All rights reserved.